{"entity":{"id":"nct02990728","kind":"trial","name":"Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer","aka":[],"tldr":"A phase 2 trial of Progestins in Endometrial cancer, run by Chang Gung Memorial Hospital, with a status the registry has not verified recently.","summary":"Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer is a phase 2 interventional study registered as NCT02990728 by Chang Gung Memorial Hospital, with 120 participants planned, started 2016-03 and due to reach its primary completion in 2018-03. Interventions recorded: Metformin, Mirena®. Conditions recorded: Endometrial Cancer.\n\nLinked to the drug Progestins because the registry names it among its interventions and Endometrial cancer among its conditions. Registry record only: no result has been read by an editor.","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT02990728","url":"https://clinicaltrials.gov/study/NCT02990728"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["endometrial"],"sections":[],"technologies":[],"targets":[],"drugs":["megestrol-progestins"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT02990728","phase":"2","setting":"Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer","sponsor":"Chang Gung Memorial Hospital","enrolled":120,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02990728/","neighbours":{"cancer":[{"id":"endometrial","kind":"cancer","name":"Endometrial cancer","route":"/cancers/endometrial/"}],"drug":[{"id":"megestrol-progestins","kind":"drug","name":"Progestins (megestrol acetate, medroxyprogesterone, levonorgestrel IUD)","route":"/drugs/megestrol-progestins/"}]}}